ABC | Volume 114, Nº1, January 2019

Original Article Silva et al. Risk stratification with reduced DAD Score Arq Bras Cardiol. 2020; 114(1):68-75 This is an open-access article distributed under the terms of the Creative Commons Attribution License 9. Friis-Moller N, Thiebaut R, Reiss P, Weber R, Monforte AD, De Wit S, et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the data  collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil. 2010;17(5):491-501. 10. Friis-Moller N, RyomL, Smith C, Weber R, Reiss P, Dabis F, et al. An updated predictionmodel of the global risk of cardiovascular disease inHIV-positive persons; the Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) Study. Eur J Prev Cardiol. 2016;23(2):214-23. 11. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a newworldwide definition. Lancet. 2005;366(9491):1059-62. 12. D’agostino RB, Vasan RS, PencinaMJ, Wolf PA, CobainM, Massaro JM, et al General cardiovascular risk profile for use in primary care: The Framingham heart study. Circulation. 2008;117(6):743–53 13. O’Leary DH, Polak J, Kronmal R, Manolio T, Burke G, Wolfson S, et al. Carotid-Artery Intima and Media Thickness As a Risk Factor for Myocardial Infarction and Stroke in Older Adults. N Engl J Med. 1999;340(1):14–22. 14. Nery MW, Martelli CMT, Aparecida Silveira E, Sousa CA De, Falco MDO, Castro ADCO De, et al. Cardiovascular risk assessment: A comparison of the Framingham, PROCAM, and DAD equations in HIV-infected persons. ScientificWorldJournal. 2013 Oct;2013:969281. 15. Falcão MC, Zírpoli JC, Albuquerque VM, Filho BM, Araújo NA, Falcão CA, et al. Associação dos Biomarcadores comAterosclerose e Risco para Doença Coronariana emPortadores de HIV. Arq Bras Cardiol. 2012;99(5):971–8. 16. Jerico C, Knobel H, Calvo N, Sorli ML, Guelar A, Gimeno-Bayon JL, et al. Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy. Stroke. 2006;37(3):812–7. 17. KrikkeM, Hoogeveen R, Hoepelman A, Visseren F, Arends J. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-. HIV Med. 2016;17(4):289–97. 18. Serrano-Villar S, Estrada V, Gómez-Garre D, ÁvilaM, Fuentes-Ferrer M, San RJ, et al. Diagnosis of subclinical atherosclerosis in HIV-infected patients: Higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms. Eur J Prev Cardiol. 2014;21(6):739–48. 19. Feinstein AR, Cicchetti DV. High agreement but low Kappa: I. the problems of two paradoxes. J Clin Epidemiol. 1990;43(6):543–9. 75